Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2201
OSI Systems
OSIS
$3.09B
| $3.67M | ﹤0.01% |
18,879
+6,878
| +57% | +$1.47M |
2013 Q2
53 quarters
|
|
2202
Brighthouse Financial
BHF
$2.61B
| $3.67M | ﹤0.01% |
73,483
-51,177
| -41% | -$2.95M |
2017 Q3
36 quarters
|
|
2203
Rapid7
RPD
$1.01B
| $3.66M | ﹤0.01% |
299,856
+178,408
| +147% | +$2.06M |
2015 Q3
44 quarters
|
|
2204
CALL
Darling Ingredients
DAR
$8.55B
| $3.64M | ﹤0.01% |
60,000
-40,000
| -40% | -$2.52M |
2025 Q2
5 quarters
|
|
|
2205
PUT
Darling Ingredients
DAR
$8.55B
| $3.64M | ﹤0.01% |
+60,000
| New | +$3.77M |
2026 Q3
0 quarters
|
|
2206
Sociedad Química y Minera de Chile
SQM
$15.6B
| $3.64M | ﹤0.01% |
56,132
-65,116
| -54% | -$4.7M |
2017 Q3
36 quarters
|
|
2207
CALL
Berkshire Hathaway Class B
BRK.B
$1.25T
| $3.64M | ﹤0.01% |
7,300
+6,600
| +943% | +$3.33M |
2024 Q4
7 quarters
|
|
2208
Sarepta Therapeutics
SRPT
$1.79B
| $3.62M | ﹤0.01% |
198,514
+70,343
| +55% | +$1.32M |
2013 Q2
53 quarters
|
|
2209
CALL
Element Solutions
ESI
$8.26B
| $3.61M | ﹤0.01% |
+99,600
| New | +$3.67M |
2026 Q3
0 quarters
|
|
2210
Boston Beer
SAM
$2.22B
| $3.6M | ﹤0.01% |
21,955
+11,631
| +113% | +$2.06M |
2013 Q2
53 quarters
|
|
2211
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.76B
| $3.6M | ﹤0.01% |
+87,298
| New | +$3.67M |
2026 Q3
0 quarters
|
|
2212
Getty Realty Corp
GTY
$1.91B
| $3.59M | ﹤0.01% |
127,288
+47,388
| +59% | +$1.56M |
2013 Q2
53 quarters
|
|
2213
Kyndryl
KD
$3.73B
| $3.59M | ﹤0.01% |
319,115
+203,255
| +175% | +$2.58M |
2022 Q1
18 quarters
|
|
2214
RXO
RXO
$4.64B
| $3.59M | ﹤0.01% |
175,618
+147,664
| +528% | +$3.36M |
2022 Q4
15 quarters
|
|
2215
CALL
Centene
CNC
$34.9B
| $3.58M | ﹤0.01% |
57,600
+45,100
| +361% | +$2.94M |
2026 Q2
1 quarter
|
|
2216
PUT
Etsy
ETSY
$7.62B
| $3.57M | ﹤0.01% |
50,000
| – | – |
2026 Q2
1 quarter
|
|
2217
DXC Technology
DXC
$2.37B
| $3.57M | ﹤0.01% |
329,445
-11,083
| -3% | -$118K |
2017 Q2
37 quarters
|
|
2218
Kohl's
KSS
$2.79B
| $3.56M | ﹤0.01% |
193,062
-723,432
| -79% | -$13.1M |
2013 Q2
53 quarters
|
|
2219
Crane NXT
CXT
$3.34B
| $3.55M | ﹤0.01% |
75,328
-276,359
| -79% | -$13.9M |
2013 Q2
53 quarters
|
|
2220
PennyMac Mortgage Investment
PMT
$651M
| $3.55M | ﹤0.01% |
450,231
+293,646
| +188% | +$2.78M |
2013 Q2
53 quarters
|
|
2221
Skeena Resources
SKE
$3.84B
| $3.54M | ﹤0.01% |
119,154
-25,169
| -17% | -$763K |
2024 Q2
9 quarters
|
|
2222
First Interstate BancSystem
FIBK
$3.5B
| $3.54M | ﹤0.01% |
98,951
+22,061
| +29% | +$834K |
2016 Q3
40 quarters
|
|
2223
Rhythm Pharmaceuticals
RYTM
$7.78B
| $3.53M | ﹤0.01% |
37,080
+23,871
| +181% | +$2.55M |
2017 Q4
35 quarters
|
|
2224
Futu Holdings
FUTU
$13.7B
| $3.53M | ﹤0.01% |
31,890
-54,731
| -63% | -$5.94M |
2020 Q2
25 quarters
|
|
2225
CALL
Replimune Group
REPL
$2.06B
| $3.52M | ﹤0.01% |
265,800
-50,100
| -16% | -$634K |
2026 Q1
2 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.